Hippocratic AI, a U.S.-based healthcare AI startup, has raised $141 million in a Series B funding round led by Kleiner Perkins, bringing its valuation to $1.64 billion. This follows a $53 million investment nine months earlier at a $500 million valuation. Prominent investors in the latest round include General Catalyst, Andreessen Horowitz (a16z), NVIDIA, Premji, SV Angel, Universal Health Services, and WellSpan Health. The company plans to use the new funding to expand its product range, enter new markets, and enhance its AI technology. Founded in 2022 by Alex Miller, Munjal Shah, and Vishal Parikh, Hippocratic AI has now raised a total of $278 million.
Hippocratic AI specializes in developing AI-powered agents for non-diagnostic, patient-focused tasks, aiming to address global healthcare workforce shortages. The company’s solutions facilitate tasks such as chronic care management and post-discharge follow-ups, improving patient access to care and enhancing care quality. A key feature of Hippocratic AI’s offering is its application store, which allows healthcare professionals to design customized AI agents tailored to their specific needs. The company is committed to making its AI agents as safe as human healthcare workers, setting a benchmark for reliable AI applications in the healthcare sector.